PARP1 and neoplasm: Although the PBMC assay used was not PARP family‐specific, as peripheral blood cells are known to express both mono (ADP‐ribosyl) transferases and several PARP family enzymes, the PARP inhibition by 10 and 20 mg/d of venadaparib in tumor tissue lysates supports effective PARP inhibition.